Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN57,6657,690,44
Msft-0,12
Nokia3,9553,97950,54
IBM1,47
Mercedes-Benz Group AG57,457,421,06
PFE0,85
05.10.2024 1:38:40
Indexy online
AD Index online
select
AD Index online
 

  • 04.10.2024 8:03:01
Orion (ORNBb.F, Frankfurt)
Poslední obchod Změna (%) Změna (EUR) Objem obchodů (EUR)
48,12 1,31 0,62 10 105
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 05.10.2024
Popis společnosti
Obecné informace
Název společnostiOrion Oyj
TickerORNBV
TickerORNAV
Kmenové akcie:Ordinary Shares Class B
Kmenové akcie:Ordinary Shares Class A
RICORNAV.HE
RICORNBV.HE
ISINFI0009014377
Poslední známé roční výsledky31.12.2023
Poslední známé čtvrtletní výsledky30.06.2024
Počet zaměstnanců k 30.06.2024 3 819
Akcie v oběhu k 23.09.2024 140 501 423
MěnaEUR
Kontaktní informace
UliceOrionintie 1A
MěstoESPOO
PSČ02200
ZeměFinland
Kontatní osoba 
Funkce kontaktní osoby 
Telefon 358 104 261
Fax358104264435

Business Summary: Orion Oyj, previously Orion Corporation, is a Finland-based company active within the pharmaceutical industry. The Company is engaged in the research and development, manufacture and marketing of human and veterinary pharmaceuticals and active pharmaceutical ingredients. The core therapy areas of the Company's pharmaceutical R&D are central nervous system (CNS) disorders, oncology and respiratory diseases.
Financial Summary: BRIEF: For the six months ended 30 June 2024, Orion Oyj revenues increased 12% to EUR636.7M. Net income applicable to common stockholders increased 19% to EUR95.8M. Revenues reflect Innovative Medicines segment increase of 46% to EUR137.5M, Branded Products segment increase of 11% to EUR141.2M, Other Countries segment increase of 60% to EUR99M, North America segment increase of 26% to EUR94.9M.
Odvětvová klasifikace
TRBC2012Pharmaceuticals (NEC)
RBSS2004Pharmaceuticals - Generic & Specialty
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICSPharmaceutical Preparation Manufacturing
NAICSMedicinal and Botanical Manufacturing
NAICS2007Pharmaceutical Preparation Mfg
NAICS2007Medicinal & Botanical Mfg
NAICS1997Pharmaceutical Preparation Manufacturing
NAICS1997Medicinal and Botanical Manufacturing
SICPharmaceutical Preparations
SICMedicinals And Botanicals



  • Poslední aktualizace: 05.10.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
President, Chief Executive Officer, Member of the Executive Management BoardLiisa Hurme5701.11.202201.01.2008
Chief Financial Officer, Member of the Executive Management BoardRene Lindell4801.05.202401.05.2024
Senior Vice President - People and Culture, Member of the Executive Management BoardJulia Macharey4701.02.202401.02.2024
Senior Vice President, Generics and Consumer Health, Member of the Executive Management BoardSatu Ahomaki5801.01.202301.01.2008
Senior Vice President, Global Operations, Fermion, Member of the Executive Management BoardJuhani Kankaanpaa4401.11.202201.11.2022
Senior Vice President, Animal Health, Member of the Executive Management BoardNiclas Lindstedt5801.01.202301.01.2023
Senior Vice President, Branded Products, Member of the Executive Management BoardHao Pan5301.01.202301.01.2023
Senior Vice President for Research and Development and Innovative Medicines, Member of the Executive Management BoardOuti Vaarala6201.01.202301.06.2020
Senior Vice President, Corporate Functions; Member of the Executive Management Board; SecretaryOlli Huotari5801.07.200601.10.2002
Employee Representative on the Executive Management BoardJani Korhonen-01.01.2018